Afuco™ Anti-PDGFRA ADCC Therapeutic Antibody (Olaratumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to PDGF-R alpha. Olaratumab is a monoclonal antibody which is for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-192 |
| Pricing | Inquiry |
| Host | Human |
| Target | PDGFRA |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | IF, IP, Neut, FuncS, ELISA, FC |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |